These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 8932982)
1. Inhibition of inflammatory cytokine production and protection against endotoxin toxicity by benzydamine. Sironi M; Pozzi P; Polentarutti N; Benigni F; Coletta I; Guglielmotti A; Milanese C; Ghezzi P; Vecchi A; Pinza M; Mantovani A Cytokine; 1996 Sep; 8(9):710-6. PubMed ID: 8932982 [TBL] [Abstract][Full Text] [Related]
2. Benzydamine protection in a mouse model of endotoxemia. Guglielmotti A; Aquilini L; Rosignoli MT; Landolfi C; Soldo L; Coletta I; Pinza M Inflamm Res; 1997 Sep; 46(9):332-5. PubMed ID: 9339387 [TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory effect of desoxo-narchinol-A isolated from Nardostachys jatamansi against lipopolysaccharide. Shin JY; Bae GS; Choi SB; Jo IJ; Kim DG; Lee DS; An RB; Oh H; Kim YC; Shin YK; Jeong HW; Song HJ; Park SJ Int Immunopharmacol; 2015 Dec; 29(2):730-738. PubMed ID: 26371857 [TBL] [Abstract][Full Text] [Related]
5. JTE-607, a novel inflammatory cytokine synthesis inhibitor without immunosuppression, protects from endotoxin shock in mice. Kakutani M; Takeuchi K; Waga I; Iwamura H; Wakitani K Inflamm Res; 1999 Aug; 48(8):461-8. PubMed ID: 10493164 [TBL] [Abstract][Full Text] [Related]
6. Differential effect of benzydamine on pro- versus anti-inflammatory cytokine production: lack of inhibition of interleukin-10 and interleukin-1 receptor antagonist. Sironi M; Massimiliano L; Transidico P; Pinza M; Sozzani S; Mantovani A; Vecchi A Int J Clin Lab Res; 2000; 30(1):17-9. PubMed ID: 10984127 [TBL] [Abstract][Full Text] [Related]
7. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit endotoxin-induced TNF-alpha production by macrophages: in vitro and in vivo studies. Delgado M; Pozo D; Martinez C; Leceta J; Calvo JR; Ganea D; Gomariz RP J Immunol; 1999 Feb; 162(4):2358-67. PubMed ID: 9973516 [TBL] [Abstract][Full Text] [Related]
8. Selection of novel analogs of thalidomide with enhanced tumor necrosis factor alpha inhibitory activity. Corral LG; Muller GW; Moreira AL; Chen Y; Wu M; Stirling D; Kaplan G Mol Med; 1996 Jul; 2(4):506-15. PubMed ID: 8827720 [TBL] [Abstract][Full Text] [Related]
9. Benzydamine reduces prostaglandin production in human gingival fibroblasts challenged with interleukin-1 beta or tumor necrosis factor alpha. Modéer T; Yucel-Lindberg T Acta Odontol Scand; 1999 Feb; 57(1):40-5. PubMed ID: 10207535 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of tumour necrosis factor and reversal of endotoxin-induced shock by U-83836E, a 'second generation' lazaroid in rats. Altavilla D; Squadrito F; Serrano M; Campo GM; Squadrito G; Arlotta M; Urna G; Sardella A; Saitta A; Caputi AP Br J Pharmacol; 1998 Jul; 124(6):1293-9. PubMed ID: 9720803 [TBL] [Abstract][Full Text] [Related]
11. Inosine inhibits inflammatory cytokine production by a posttranscriptional mechanism and protects against endotoxin-induced shock. Haskó G; Kuhel DG; Németh ZH; Mabley JG; Stachlewitz RF; Virág L; Lohinai Z; Southan GJ; Salzman AL; Szabó C J Immunol; 2000 Jan; 164(2):1013-9. PubMed ID: 10623851 [TBL] [Abstract][Full Text] [Related]
12. IL-4 pretreatment selectively enhances cytokine and chemokine production in lipopolysaccharide-stimulated mouse peritoneal macrophages. Major J; Fletcher JE; Hamilton TA J Immunol; 2002 Mar; 168(5):2456-63. PubMed ID: 11859138 [TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo therapeutics of β-thujaplicin on LPS-induced inflammation in macrophages and septic shock in mice. Shih MF; Chen LY; Tsai PJ; Cherng JY Int J Immunopathol Pharmacol; 2012; 25(1):39-48. PubMed ID: 22507316 [TBL] [Abstract][Full Text] [Related]
16. Treatment with Y-40138, a multiple cytokine production modulator, inhibits lipopolysaccharide- or tumour necrosis factor-alpha-induced production of pro-inflammatory cytokines and augments interleukin-10. Fukuda T; Hisadome M; Komatsu H J Pharm Pharmacol; 2005 Nov; 57(11):1461-6. PubMed ID: 16259779 [TBL] [Abstract][Full Text] [Related]
17. Lipopolysaccharide-induced cytokine production and mortality in mice treated with Corynebacterium parvum. Smith SR; Calzetta A; Bankowski J; Kenworthy-Bott L; Terminelli C J Leukoc Biol; 1993 Jul; 54(1):23-9. PubMed ID: 8336076 [TBL] [Abstract][Full Text] [Related]
18. Temporal sequence of pulmonary cytokine gene expression in response to endotoxin in C3H/HeN endotoxin-sensitive and C3H/HeJ endotoxin-resistant mice. Nill MR; Oberyszyn TM; Ross MS; Oberyszyn AS; Robertson FM J Leukoc Biol; 1995 Nov; 58(5):563-74. PubMed ID: 7595058 [TBL] [Abstract][Full Text] [Related]
19. Is circulating endotoxin the trigger for the systemic inflammatory response syndrome seen after injury? Kelly JL; O'Sullivan C; O'Riordain M; O'Riordain D; Lyons A; Doherty J; Mannick JA; Rodrick ML Ann Surg; 1997 May; 225(5):530-41; discussion 541-3. PubMed ID: 9193181 [TBL] [Abstract][Full Text] [Related]
20. Inflammatory cytokine production in interferon-gamma-primed mice, challenged with lipopolysaccharide. Inhibition by SK&F 86002 and interleukin-1 beta-converting enzyme inhibitor. Spinelle-Jaegle S; Devillier P; Doucet S; Millet S; Banissi C; Diu-Hercend A; Ruuth E Eur Cytokine Netw; 2001; 12(2):280-9. PubMed ID: 11399517 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]